Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCHU de Reims

About this trial

Microbial keratitis is a severe and often blindness-inducing pathology which represents today the first reason for long-term hospitalization (more than 5 days) in ophthalmology. Its diagnosis is clinical and leads to an immediate hospitalization in the presence of serious criteria (Mackie classification). The entire process of microbiological diagnosis requires several days before etiological confirmation and therefore delays the initiation of targeted therapy.

Recently, new PCR systems allowing the detection of 18 to 27 pathogens in 75 minutes have been developed. Their use could thus be transposed to ophthalmology by adapting the microbiological diagnostic technique to samples currently taken by swabbing the cornea.

The investigators will compare their diagnosis performance versus conventional methods on patients who suffered for a microbial keratitis with severity criteria.

Eligibility criteria

Qualifiers

Over 18 years old

With social security affiliation

Willing to participate this study

Hospitalized in our department for severe infectious keratitis

Disqualifiers

None

Trial design

Treatments tested in this trial

  • PCR multiplex by FilmArray

Treatment groups

46 Participants
are divided into 2 treatment groups

Sponsors and collaborators